CompletedNot Applicable

The Cellularity Yield of Three Different 22-gauge FNA Needles

United States107 participantsStarted 2012-09

Plain-language summary

Obtaining a sample from a lesion in the gastrointestinal tract by endoscopic ultrasound (a flexible tube with a camera and small ultrasound machine at its end )requires the use of a needle for taking the sample from the lesion or what we call "Fine needle aspiration (FNA)". Currently, FNA is done by three commercially available needles. These needles are used routinely in our institution for FNA. The data regarding the safety and the successfulness of any of these needles are lacking. We sought to compare all three commercially available needles in a prospective manner.

Who can participate

Age range18 Years – 88 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients (18-88) who are undergoing EUS FNA of pancreatic or peripancreatic lesions
✓. Adult patients (18-88) who are undergoing EUS FNA of submucosal masses in the esophagus, stomach, duodenum or rectum
✓. Adult patients (18-88) who are undergoing EUS FNA of mediastinal masses.
✓. Adult patients (18-88) who are undergoing EUS FNA of enlarged lymph nodes

Exclusion criteria

✕. Patients younger than 18 yrs old or older than 88 yrs.
✕. Pregnant patients

What they're measuring

1. Compare the overall diagnostic accuracy of the three commercially available 22 gauge EUS needles

Timeframe: 2 days after the procedure

Trial details

NCT IDNCT01916421

SponsorTexas Tech University Health Sciences Center, El Paso

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-09

View on ClinicalTrials.gov More Pancreatic or Peripancreatic Lesions trials